Does HLA-B*2706 protect against ankylosing spondylitis? A meta-analysis

International Journal of Rheumatic Diseases

Volumn 15, Issue 1, 2012, Pages 8-12

  van Gaalen, Floris Alexander ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

2706; Ankylosing spondylitis; Genetics; HLA B; HLA B27; Spondyloarthritis

Indexed keywords

HLA B ANTIGEN; HLA B2706 ANTIGEN; UNCLASSIFIED DRUG; HLA B*27:06 ANTIGEN; HLA B27 ANTIGEN; HLA-B*27:06 ANTIGEN;

ANKYLOSING SPONDYLITIS; COMPARATIVE STUDY; DATA SYNTHESIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; GENETICS; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SOUTHEAST ASIA; SYSTEMATIC REVIEW; CASE CONTROL STUDY; GENE FREQUENCY; GENOTYPE; IMMUNOLOGY; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR;

CASE-CONTROL STUDIES; GENE FREQUENCY; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 84857054824     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01676.x     Document Type: Review

References (18)

1. Benjamin R, Parham P (1990) Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today11, 137-42.
2. Ball EJ, Khan MA (2001) HLA-B27 polymorphism. Joint Bone Spine68, 378-82.
3. Khan MA (2010) Remarkable polymorphism of HLA-B27: an ongoing saga. Curr Rheumatol Rep12, 337-41.
4. Dhaliwal JS, Too CL, Lisut M, Lee YY, Murad S (2003) HLA-B27 polymorphism in the Malays. Tissue Antigens62, 330-2.
5. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG (2006) Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol13, 50.
6. Lopez-Larrea C, Sujirachato K, Mehra NK, et al. (1995) HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens45, 169-76.
7. Nasution AR, Mardjuadi A, Kunmartini S, et al. (1997) HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol24, 1111-4.
8. Ren EC, Koh WH, Sim D, Boey ML, Wee GB, Chan SH (1997) Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens49, 67-9.
9. Gonzalez-Roces S, Alvarez MV, Gonzalez S, et al. (1997) HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens49, 116-23.
10. Chen IH, Yang KL, Lee A, Huang HH, Lin PY, Lee TD (2002) Low frequency of HLA-B*2706 in Taiwanese patients with ankylosing spondylitis. Eur J Immunogenet29, 435-8.
11. Yang KL, Chen IH, Hsiao CK, et al. (2004) Polymorphism of HLA-B27 in Taiwanese Chinese. Tissue Antigens63, 476-9.
12. Ma HJ, Hu FP (2006) Diversity of human leukocyte antigen-B27 alleles in Han population of Hunan province, southern China. Tissue Antigens68, 163-6.
13. Hou TY, Chen HC, Chen CH, Chang DM, Liu FC, Lai JH (2007) Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience. Intern Med J37, 749-52.
14. Duangchanchot M, Puapairoj C, Romphruk A, Kongmaroeng C, Leelayuwat C, Romphruk AV (2009) HLA-B*27 subtypes in Northern and Northeastern Thais, Karens, and Bamars determined by a high-resolution PCR-SSP technique. Tissue Antigens73, 590-4.
15. Liu Y, Jiang L, Cai Q, et al. (2010) Predominant association of HLA-B*2704 with ankylosing spondylitis in Chinese Han patients. Tissue Antigens75, 61-4.
16. Stewart AG (2010) HLA-B27 polymorphism associated with disease in a New Zealand population. NZ J Med Lab Science64, 78-84.
17. Sudarsono D, Hadi S, Mardjuadi A, et al. (1999) Evidence that HLA-B*2706 is not protective against spondyloarthropathy. J Rheumatol26, 1534-6.
18. Zawacka A, Loll B, Biesiadka J, Saenger W, Uchanska-Ziegler B, Ziegler A (2005) X-ray diffraction analysis of crystals from the human major histocompatibility antigen HLA-B*2706 in complex with a viral peptide and with a self-peptide. Acta Crystallogr Sect F Struct Biol Cryst Commun1, 1097-9.